Beroe

See the following -

Open Source Paradigm Could Swipe Biz From CROs: Beroe

Natalie Morrison | Outsourcing-Pharma.com | September 27, 2012

However “open source” drug discovery – by which a contractor buys a compound with little data, shares that data with a sponsor and then provides development services for a fee – could be a way to plug the gaps, Pakaravoor told us.

Read More »